Screening and Identification of a Six-Cytokine Biosignature for Detecting TB Infection and Discriminating Active From Latent TB

Journal of Translational Medicine - United Kingdom
doi 10.1186/s12967-018-1572-x
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Latent TB Infection

The Singapore Family Physician
2017English

QuantiFERON-TB Gold Test for Screening Latent Tuberculosis Infection in Hemodialysis Patients

Tuberkuloz ve Toraks
PulmonaryCritical CareRespiratory MedicineSurgeryIntensive Care Medicine
2011English

Further Evidence Supporting Programmatic Screening For, and Treatment of Latent TB Infection (LTBI) in New Entrants to the UK From High TB Prevalence Countries

Thorax
PulmonaryRespiratory Medicine
2012English

Effect of Diabetes Mellitus on Risk of Latent TB Infection in a High TB Incidence Area: A Community-Based Study in Taiwan

BMJ Open
Medicine
2019English

Pyrido[1,2-A]benzimidazole-Based Agents Active Against Tuberculosis (TB), Multidrug-Resistant (MDR) TB and Extensively Drug-Resistant (XDR) TB

ChemMedChem
Organic ChemistryMolecular MedicinePharmacologyBiochemistryToxicologyDrug DiscoveryPharmaceutics
2011English

Guidelines for Using the QuantiFERON(R)-TB Test for Diagnosing Latent Mycobacterium Tuberculosis Infection

2003English

Treatment of Latent TB: First Do No Harm

Expert Review of Anti-Infective Therapy
VirologyInfectious DiseasesMicrobiology
2011English

TB Screening in Physicians' Offices

Infection Control and Hospital Epidemiology
EpidemiologyInfectious DiseasesMicrobiology
1999English

Childhood TB Epidemiology and Treatment Outcomes in Thailand: A TB Active Surveillance Network, 2004 to 2006

BMC Infectious Diseases
Infectious Diseases
2008English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy